Investors who are bullish on AI might want to avoid this sector.
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
The stock market may have hit a wall, but the S&P 500 price targets keep going higher. The strategists at J.P. Morgan were the latest to raise their target: Dubravko Lakos-Bujas of J.P. Morgan wrote in a note Wednesday that he and his team were upping their year-end target to 7800 from 7600. The S&P 500 was up 0.2% to about 7383 on Wednesday.
The solar-energy company is partnering with home energy platform Renew Home and electric car maker Tesla to power data centers.
Nasdaq 100 futures rose 0.6% after a two-day AI valuation selloff hit major technology stocks.
June 24 (Reuters) - Wall Street's main indexes were muted on Wednesday, after two straight sessions of declines, as technology shares steadied after a sharp sell-off this week and investors awaited
Nature's Sunshine has been treading water for the past six months, recording a small loss of 4.7% while holding steady at $20.81. The stock also fell short of the S&P 500’s 7.8% gain during that period.
Portfolio size, sector mix, and underlying index set these two low-cost funds apart for investors seeking small-cap exposure.
Burke Wealth Management, an investment management company, released its “Focused Growth Strategy” first-quarter 2026 investor letter. A copy of the letter can be downloaded here. The Fund returned -10.6% in Q1 2026, significantly lagging the S&P 500’s -4.3% returns. The letter noted the quarter as the worst for equities since 2022, with strong corporate earnings being […]
IBM (IBM) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Burke Wealth Management, an investment management company, released its “Focused Growth Strategy” first-quarter 2026 investor letter. A copy of the letter can be downloaded here. The Fund returned -10.6% in Q1 2026, significantly lagging the S&P 500’s -4.3% returns. The letter noted the quarter as the worst for equities since 2022, with strong corporate earnings being […]
The new Fed chair didn't change the Fed funds rate this month, but there were notable policy changes.
Over the past six months, CNX Resources’s shares (currently trading at $33.32) have posted a disappointing 9.9% loss, well below the S&P 500’s 7.8% gain. This might have investors contemplating their next move.
Burke Wealth Management, an investment management company, released its “Focused Growth Strategy” first-quarter 2026 investor letter. A copy of the letter can be downloaded here. The Fund returned -10.6% in Q1 2026, significantly lagging the S&P 500’s -4.3% returns. The letter noted the quarter as the worst for equities since 2022, with strong corporate earnings being […]
How do these two tech ETFs stack up?
Invesco has been treading water for the past six months, holding steady at $27.29. The stock also fell short of the S&P 500’s 7.8% gain during that period.
US equity futures were slightly higher pre-bell Wednesday as technology stocks rebounded after a bro
Don't assume some rising S&P 500 stock have gotten away from you. Analysts are unanimously supporting a few of them.
Over the last six months, Waters Corporation’s shares have sunk to $357.08, producing a disappointing 7.2% loss - a stark contrast to the S&P 500’s 7.8% gain. This may have investors wondering how to approach the situation.
The bullish call comes as all three remained unprofitable due to non-cash Bitcoin writedowns, and investors question AI data center demand.
Over the past six months, Ocular Therapeutix’s shares (currently trading at $10.37) have posted a disappointing 18.5% loss, well below the S&P 500’s 7.8% gain. This was partly due to its softer quarterly results and might have investors contemplating their next move.
Explore how these two funds differ in credit quality, diversification, and income potential for long-term bond investors.
It's a traditional business that has capitalized on hot opportunities with a cutting-edge technology.
One ETF leans into technology and dividend growth, while the other prioritizes higher income and lower volatility. Which approach better fits your portfolio?
Wall Street analysts anticipate more upside for U.S. stocks in the second half of 2026.